drugset / Trial / NCT01737580
Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
RandomizedParallel-groupTriple-blindTreatment
Summary
The application of the TLR7/8 (Toll Like Receptor) agonist gel (immune response helper) resiquimod will enhance the immune response to the intradermal influenza vaccine in seniors 65-75 years of age.
Timeline
- Start
- 2013-04
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Resiquimod | Small molecule | — | Topical |
Indications
No indication recorded.